These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14723346)

  • 1. Enhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticles.
    Yu BT; Sun X; Zhang ZR
    Arch Pharm Res; 2003 Dec; 26(12):1096-101. PubMed ID: 14723346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.
    Chen DB; Yang TZ; Lu WL; Zhang Q
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1444-7. PubMed ID: 11724235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.
    Wang JX; Sun X; Zhang ZR
    Eur J Pharm Biopharm; 2002 Nov; 54(3):285-90. PubMed ID: 12445558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.
    Khallaf RA; Salem HF; Abdelbary A
    Drug Deliv; 2016 Nov; 23(9):3452-3460. PubMed ID: 27240935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles].
    Li JJ; Yang GD; Wang HY; Zhang SQ
    Yao Xue Xue Bao; 2008 Jul; 43(7):761-5. PubMed ID: 18819483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
    Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
    J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages.
    Costa A; Sarmento B; Seabra V
    Eur J Pharm Sci; 2018 Mar; 114():103-113. PubMed ID: 29229273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
    Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
    J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
    Du B; Yan Y; Li Y; Wang S; Zhang Z
    Pharm Dev Technol; 2010; 15(4):346-53. PubMed ID: 19769532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
    Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
    J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
    Cheng M; Ma D; Zhi K; Liu B; Zhu W
    Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
    Lai LF; Guo HX
    Int J Pharm; 2011 Feb; 404(1-2):317-23. PubMed ID: 21094232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.
    Al Sabbagh C; Tsapis N; Novell A; Calleja-Gonzalez P; Escoffre JM; Bouakaz A; Chacun H; Denis S; Vergnaud J; Gueutin C; Fattal E
    Pharm Res; 2015 May; 32(5):1585-603. PubMed ID: 25416027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on 5-fluorouracil solid lipid nanoparticles (SLN) prepared by hot homogenization.
    Mao S; Wang P; Bi D
    Pharmazie; 2005 Apr; 60(4):273-7. PubMed ID: 15881607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.